The lancet oncology
The most recent articles from:
Lancet Oncol.
-
The lancet oncology · Nov 2012
A whole-blood RNA transcript-based prognostic model in men with castration-resistant prostate cancer: a prospective study.
Survival for patients with castration-resistant prostate cancer is highly variable. We assessed the effectiveness of a whole-blood RNA transcript-based model as a prognostic biomarker in castration-resistant prostate cancer. ⋯ Source MDX.